Carter DM - Search Results

1

Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.

Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J. Smoller BA, et al. Among authors: carter dm. Arch Dermatol. 1990 Jan;126(1):78-83. Arch Dermatol. 1990. PMID: 1688702

2

Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis.

Krane JF, Murphy DP, Gottlieb AB, Carter DM, Hart CE, Krueger JG. Krane JF, et al. Among authors: carter dm. J Invest Dermatol. 1991 Jun;96(6):983-6. doi: 10.1111/1523-1747.ep12476485. J Invest Dermatol. 1991. PMID: 1646268 Free article.

3

Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways.

Khandke L, Krane JF, Ashinoff R, Staiano-Coico L, Granelli-Piperno A, Luster AD, Carter DM, Krueger JG, Gottlieb AB. Khandke L, et al. Among authors: carter dm. Arch Dermatol. 1991 Aug;127(8):1172-9. doi: 10.1001/archderm.127.8.1172. Arch Dermatol. 1991. PMID: 1677800

4

Junctional epidermolysis bullosa keratinocytes in culture display adhesive, structural, and functional abnormalities.

Krueger JG, Lin AN, Leong I, Carter DM. Krueger JG, et al. Among authors: carter dm. J Invest Dermatol. 1991 Nov;97(5):849-61. doi: 10.1111/1523-1747.ep12491525. J Invest Dermatol. 1991. PMID: 1717612 Free article.

5

Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis.

Krueger JG, Krane JF, Carter DM, Gottlieb AB. Krueger JG, et al. Among authors: carter dm. J Invest Dermatol. 1990 Jun;94(6 Suppl):135S-140S. doi: 10.1111/1523-1747.ep12876121. J Invest Dermatol. 1990. PMID: 2161887 Free article. Review.

6

The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor.

Krane JF, Gottlieb AB, Carter DM, Krueger JG. Krane JF, et al. Among authors: carter dm. J Exp Med. 1992 Apr 1;175(4):1081-90. doi: 10.1084/jem.175.4.1081. J Exp Med. 1992. PMID: 1313074 Free PMC article.

7

Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.

Gottlieb AB, Grossman RM, Khandke L, Carter DM, Sehgal PB, Fu SM, Granelli-Piperno A, Rivas M, Barazani L, Krueger JG. Gottlieb AB, et al. Among authors: carter dm. J Invest Dermatol. 1992 Mar;98(3):302-9. doi: 10.1111/1523-1747.ep12499782. J Invest Dermatol. 1992. PMID: 1372027 Free article.

8

Hypertriglyceridemia in patients with psoriasis treated with cyclosporine.

Grossman RM, Delaney RJ, Brinton EA, Carter DM, Gottlieb AB. Grossman RM, et al. Among authors: carter dm. J Am Acad Dermatol. 1991 Oct;25(4):648-51. doi: 10.1016/0190-9622(91)70247-y. J Am Acad Dermatol. 1991. PMID: 1791223

9

Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor.

Krane JF, Murphy DP, Carter DM, Krueger JG. Krane JF, et al. Among authors: carter dm. J Invest Dermatol. 1991 Apr;96(4):419-24. doi: 10.1111/1523-1747.ep12469799. J Invest Dermatol. 1991. PMID: 1848876 Free article.

10

Atypical melanocytic lesions in epidermolysis bullosa.

Hoss DM, McNutt NS, Carter DM, Rothaus KO, Kenet BJ, Lin AN. Hoss DM, et al. Among authors: carter dm. J Cutan Pathol. 1994 Apr;21(2):164-9. doi: 10.1111/j.1600-0560.1994.tb00252.x. J Cutan Pathol. 1994. PMID: 8040465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters